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Certain new 3·[«( a-phenyllmethyl)benzylidene)amino )oxy] methyl/ethyl-t-amino-Svrnercapto-I ,2,4-
triazoles 4a-d, have been prepared starting from a/p-[«a-(phenyllmethyl)benzylidene) amino )oxy]
acetic/propionic acid esters Ia-d. The esters 1a-d, are converted into the corresponding hydrazides 2a-d,
by refluxing tbern with 99% hydrazine hydrate. The potassium salts of dithiocarbazinates 3a-d, are
obtained by stirring hydrazides 2a-d with alcoholic potassium hydroxide and carbon disulphide.
Potassium salts of dithiocarbazinate 3a-d, when refluxed with two fold excess of hydrazine hydrate,
afford the parent triazoles 4a-d. The structures of the compounds have been characterised by elemental
and spectral (IR, IHNMR and mass) analysis. All the newly synthesised 1,2,4-triazoles have been
screened for antiinflammatory activity by carrageenan induced rat paw edema and cotton pellet induced
granulation tissue formation methods. The same compounds have also been screened for their
ulcerogenic liability and antimicrobial activity against E coli, B. cirrojlagel/osus, A. niger and R.
bataticola. Some of the newly synthesised compounds have been evaluated for antituberculosis activity
against Mycobacterium tuberculosis H37Rv strain as well.
1,2,4-Triazoles are associated with diverse
pharmacological activities!". Previous experi-
mental and theoretical studies" in the field of
adrenergic drugs have indicated that at least in the
case of these type of drugs, the "methylene amino
oxy methyl moiety" (=C=N-O-CH2-' MAOMM)
can be considered as a "biostere'" of either aryls
(Ar) or other aromatic groups (Figure 1/. These
results suggested that it might be possible to effect
the substitution of an Ar with the MAOM moiety
in drugs other than adrcnergies in which the Ar
group seems to be a prerequisite for eliciting
biological activity.".
Encouraged by these observations and
established pharmacological activities such as
antidepressant", 5-HT-uptake inhibition",
-o'
Figure I -Representation of the biosterism between
Ar and MAOMM
antianginal", l3-adrenoreceptor blocking":", blood
pressure lowering'v':', hypocholesterolernic'v"
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compounds with MAOMM, it was contemplated to
incorporate the MAOM moiety at the third position
of the triazole moiety. To enable further evaluation
of the potential usefulness of 1,2,4-triazoles and in
continuation of our search for 1,2,4-triazoles as
pharmacologically active heterocyclesr':", we
report herein the synthesis of SJlile new 3-[«(a-
phenyl/methyljbenzylidene )-amino )oxy ]methyl/et-
hyl-4-amino-5-mercapto-l,2,-4-triazoles 4a-d with
a view to achieve better antiinflammatory and least
ulcerogenecity. The same compounds were also
screened for their antimicrobial activity against E.
coli, B, cirroflagellosus, C. albicans, R. bataticola
and antituberculosis activity against M
tuberculosis H37Rv strains. The synthetic route for
the title compounds is depicted in Scheme L
In the present investigation, a-[(((a-
phenyllmethyl)benzylidene )amino )oxy] ethyl ace-
tates la-b were prepared by refluxing oximes with
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Where, R = C6 H 5 ; Rl = C 6 H 5; CH 2; R2 = C 2 H 5, CH 3; n = 1,2.
Scheme I
ethyl chloroacetate In presence of anhyd.
potassium carbonate and acetone. Oximes on
condensation with methyl acrylate in the presence
of catalytic amount of triethylamine furnished
methyl ~-[ « (a-phenyl/-methy I)-benzyl idene )-ami-
no )-oxy] propionates Ic-d. Ethyl/methyl esters of
a/~-[((( a-phenyllmethyl) benzyl idene )amino )oxy]-
acetic/propionic acids La-d (Table I), were
converted to the corresponding a/~ -[((( a-
phenyllmethyl)benzyl idene )amino )oxy ]acetic/prop
ionic acid hydrazides 2a-d (Table II), by retluxing
with hydrazine hydrate (99%) in abs. ethanol.
Potassium salts of a/~-[(((a-phenyllmethyl)-
benzylidene) amino) oxy] acetyllpropionyl
dithiocarbazinates 3a-d were obtained by stirring
hydrazides 2a-d with alcoholic potassium
hydroxide and carbon disulphide. Potassium salts
of 3a-d on reaction with two fold excess of
hydrazine hydrate yielded 3-[(((a-phenyll-
methyl)benzylidene )amino )oxy] methyl/ethyl-a-
amino-5- mercapto-4(H)-1,2,4- triazoles 4a-d
(Table III). The structures of the newly synthesised
compounds were confirmed by elemental and
spectral (IR, IHNMR and mass) analysis.
Pharmacological evaluation
After establishing the physicochemical
properties of triazoles 4a-d, the compounds were
subjected to pharmacological screening.
(i) Acute toxicity study. Newly synthesised
triazoles 4a-d were first subjected for acute
toxicity study in order to determine their LD50. The
study was carried out according to the method of
Miller and Tainter26 The test samples 4a-d, failed
to produce any mortality even up to the dose of
900 mgllOO g b.w .. by oral route of administration.
When all the test samples 4a-d, were administered
Table I-Physicochemical data of ethyl/methyl esters of a/P-[«(a-phenyl/mcthyl)bcnzylidene)
amino)oxy] acetic/propionic acids la-d
oR II







m.p., Yield Mol. Analysis (%) Calc. (Found)
(0C) (%) Formula C H N
116-18 70 C17H17NO} 72.07 6.05 4.94
(71.90) (5.90) (4.75)
oil 58 CI2H1,NO] 65.14 6.83 6.33
(65.01 ) (6.53) (6.00)
96-97 73 CI8HI9NO] 72.70 6.44 4.71
(72.56) (632) (4.55)
oil 60 CIlHI7NO) 66.36 7.28 5.95
(66.21 ) (7.06 ) (5.80)
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Table II-Physicochemical data ofhydrazides of a/p-[«(a-phenyllmethyl)benzylidene)

































R ./ 2 n N
1 I
NH2
m.p., Yield Mol. Analysis (%) Calc. (Found)
(0C) (%) formula C H N
220-21 35 CI6HISNsOS 59.06 4.64 21.52
(59.02) (4.60) (21.49)
105-06 37 CIIH13NsOS 50.18 4.98 26.59
(50.00) (4.94) (26.54)
218-19 39 C17H17NSOS 60.16 5.05 20.63
(60.00) (5.01 ) (20.59)





.various viscera was done for any ulcer formation
on the inner surface of the stomachs.
There were no ulcerogenic changes, except mild
congestion of the stomachs from compounds
treated groups. But one to two necrohaemorrhagic
spots were observed on the inner surface of the
stomachs from the ibuprofen treated group.
.Intraperitoneally, only compound 4d, showed
increased toxicity and a mortality rate of 83
percent at a dose of40 mg/IOO g b.w. Remaining
compounds 4a, 4b and 4c did not show mortality at
the same dose. LDso of the compound 4d, by
intraperitoneal route is 31.62± 1.4011 00 g b.w.
(ii) Antiinflammatory activity. The anti-
inflammatory activity of triazoles 4a-d was studied
by the following methods: (a) carrageenan induced
rat paw edema method due to winter et al.27, and
cotton pellet induced granulation tissue formation
method due to Meir et a12R,
All the results and statistical data like SE and p
for all the three doses 10, 20 and 40 mg/IOO g b.w.,
are recorded in Tables IV and V.
(iii) Ulcerogenic liability. After removing the
cotton pellets the abdomen of all the animals were
opened and the naked eye examination of the
Biological evaluation
(i) Evaluation of antimicrobial activity. Some of
the newly synthesised compounds were evaluated
for their antimicrobial activity against Gram
negative bacterium Escherichia coli, Gram positive
bacterium Bacillus cirrojlagellosus and fungi
Aspergillus niger, Rhizoctonia bataticola, by cup
plate method29.
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(ii) Evaluation of Antituberculosis activity. Some
of the newly synthesised compounds were tested
for their antituberculosis activity against M
tuberculosis H37Rv by Bactec 460 radiometric
system at Southern Research Institute, Frederick
Research Center, Frederick MD.
(iii) In vitro evaluation of antituberculosis activity.
Primary screening of in vitro antituberculosis
activity was conducted at a concentration of .12.5
ug/ml. against Mycobacterium tuberculosis H37Rv
in BACTEC 12B medium using the BACTEC 460
radiometric system. The antituberculosis activity of
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Table V-Results of antiinflammatory activity of compounds 4a-d using














































































all the newly synthesised compounds are compared
with the standard, Rifampin (which has 96%
inhibition at a MIC of 0.031 ug/rnl.).
Results and Discussion
In the carrageenan induced rat paw edema
method triazoles 4a-d, exhibited significant
antiinflammatory activity comparable with that of
the standard ibuprofen (Table IV).
The antiinflammatory activity of the compounds
4a-d, is dose dependent and is maximum at the end
of the third hour. At 40 mg/IOO g b.w., all the
compounds 4b, 4d, 4c, and 4a exhibited
antiinflammatory activity in the order of 68.90,
66.37, 60.21, 58.64% respectively, whcih are
comparable to the activity shown by ibuprofen
(69.05%). Cotton pellet granulation tissue
formation studies indicated that, both triazoles 4a-
d and ibuprofen have exhibited moderate degree of
antiinflammatory activity. The activity in this
method of testing is also dose dependent.
Compounds 4b and 4d exhibited the activity in the
order of 17.85 and 17.09% respectively, which are
comparable to the activity exhibited by ibuprofen
(20.13%). However the remaining compounds 4a
and 4c exhibited moderate to minimum
antiinflammatory activity (Table V).
During the present investigation all the triazoles
4a-d, have shown lesser degree of ulcerogenecity
as compared to the standard ibuprofen.
Amongst all the compounds screened for
antimicrobial activity, the hydrazides 2a-d,
exhibited better antibacterial activity against E.
coli, (153.33-359.04%, relative percent inhibition
with respect to the standard cotrimoxazole) and
antifungal activity against R. bataticola (153.33-
247.61 %, relative percent inhibition with respect to
the standard Fluconazole) than the parent triazoles
4a-d (76.19-282.86% and 100-182.05
respectively). However, both hydrazides and
triazoles exhibited moderate antimicrobial activity
against B. cirrojlagellosus (23.80-166.96%) and A.
niger (20.72-78.76) respectively. Amongst the
various compounds screened for antituberculosis
activity against Mycobacterium tuberculosis,
H37Rv, only compound 4b, exhibited 78 percent
inhibition, in comparison to Rifampin, which has
96 percent inhibition at a concentration of 0.031
ug/rnl.. Remaining compounds exhibited minimum
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to moderate antituberculosis activity (24-35%)
against the same strain.
Structure activity relationship
From the results of antimicrobial screening the
following structure activity relationship (SAR) are
generalized.
From the above observations, we notice that the
replacement of C6H5 by CH3 group in the
methylene amino oxy methyl moiety, MAOMM,
did not appear to alter the antimicrobial and
antiinflammatory activity appreciably. Hence, it is
concluded that the biologically active biostere
'Methylene Amino Oxy Methyl Moiety
(MAOMM), is responsible for the significant
antiinflammatory and antimicrobial activities of
the compounds.
Experimental Section
Melting points were determined in open
capillaries and are uncorrected. IR spectra in KBr,
were recorded on a Perkin Elmer
spectrophotometer and 'HNMR spectra on varian
300 MHz N¥R spectrometer using TMS as an
internal standard (chemical shifts in 0 ppm). Mass
spectra were recorded on Finnig Mat 8230
spectrometer. The starting materials benzophenone
oxime and acetophenone oximes (lit. m.p. 142°C
and 59°C respectively), were prepared by
literature methods.3o,3! The observed melting points
were consistant with the melting points reported in
the literature.
General procedure for the preparation of ethyl
esters of a-[ «( a-phenyl/methyl benzylidene )-
amino)oxy]acetic acids la-b. A mixture of
benzophenone oxime (0.1 mole) and anhyd. K2C03
(13.8 g, 0.1 mole) were treated with acetone (35
mL) and the resulting mixture was stirred at reflux
temperature for 3 hr. To the stirred suspension
ethyl chloroacetate (12.25 g, 0.1 mole) in acetone
(15 mL) was added and refluxing was continued
for 8 hr. The excess of acetone was removed in
vacuo and the residual mass poured onto crushed
ice. The solid separated was filtered, washed
thoroughly with water, dried and crystallised from
ethanol. la: IR: 1590 (>C=N), 940 (=N-O), 2965
(CH2), 1660 ern (>C=O).
General procedure for the preparation of
methyl esters of [3-[«(a-phenyl(methyl)benzy-
Iidene)-amino)oxy]propionic acids lc-d. To a
well stirred solution of benzophenone oxime (0.1
mole) and triethyl amine (3 mL) in abs. ethanol (40
mL), methyl acrylate (8.9 g, 0.1 mole) was added
and the resulting reaction mixture was refluxed for
9 hr. After evaporation in vacuo, the residual mass
was poured over crushed ice. The solid separated
was filtered, washed with water and crystall ized
from ethanol. lc: IR: 1605 (>C=N-), 935 (=N-O-),
2950 (CH2), 1675 em" (>C=O).
General procedure for the preparation of
hydrazides of a/[3-[ «( a-phenyl/methyl)benzyli-
dene) amino)oxy]acetic/propionic acids 2a-d. To
a solution of ester la-d (0.05 mole) in abs. ethanol
(50 mL) was added hydrazine hydrate 99%, (2.25
g, 0.05 mole) dropwise with cooling. The resulting
reaction mixture .was refluxed for 6 hr. Con-
centration in vacuo left residue, which was poured
onto crushed ice. The solid separated was filtered,
washed with water, dried and crystallised from
ethanol 2a: IR: 1~80 (>C=N-), 970 (=N-O-), 2950
(CH2), 1685 (>C=O-) 3200 and 3120 (-NH2)- 3300
ern" (-NH-); 2c: IR: 1600 (>C=N), 950 (=N-O-),
2930 (CH2), 1690 (>C=O), 3225 and 3115 (-NH2-)'
3325 em' (-NH-).
General procedure for the preparation of
potassium a/[3-[ «( a-phenyl/methyl)benzyli-
dene )amino )oxy ]acetyl/propionyl dithiocarba-
zinates 3a-d.To a well stirred clear solution of
KOH (3.36 g, 0.06 mole) in abs. ethanol (15 mL),
was added hydrazide 2a-d (0.04 mole), with
stirring and cooling in ice. To this, carbon
disulphide (3.12 g, 0.06 ,mole) was added in small
portions. The reaction mixture was stirred
continuously for 12 hr and diluted with anhyd.
ether (200 mL). The potassium dithiocarbazinate
that separated was filtered, washed several times
with anhyd. ether and dried in vacuo. The
potassium salt obtained in quantitative yield, was
moisture sensitive and hence used directly for the
preparation of the 'corresponding triazole without
further purification.
General procedure for the preparation of 3-
[«(a-phenyl/methyl) benzylidene) amino )oxy]-
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methyl/ethyl-4-amino-5-mercapto-4(H)-1,2,4-
tri-azoles 4a-d. To a solution of potassium
dithiocarbazinate, 3a-d (0.04 mole) in water (10
mL), was added hydrazine hydrate 99% (4.0 g,
0.08 mole) and the reaction mixture was refluxed
for 3 hr. The colour of the mixture turned from red
to green, with the evolution of hydrogen sulphide
gas (lead acetate paper test and odour). The clear
solution was treated with decolorising charcoal,
filtered, cooled in ice and then carefully acidified
with acetic acid. The precipitated solid was
filtered, washed with water, dried and crystallized
from abs. ethanol. 4a: IR: 960 (=N-O-), 2960
(CH2), 1610 (>C=C<), 1580 (>C=N-), 1470 (>C-
N-), 1265 and 1175 (>C=S), 3200 and 3125 (NH2),
3120 em" (-NH-); 4b: IR: 940 (=N-O-), 2965
(CH2), 1605 (>C=C<), 1595 (>C=N-), 1490 (>C-N-
), 1275 and 1190 (>C=S), 3225 and 3115 (NH2),
3280 em" (NH-): 4a : 'HNMR (OMSO-d6): 5.18
(s, 2H, CH2), 5.62 (s, 2H, NH2, 020-
exchangeable), 13.78 (br.S, IH, -NH-C=S, 020-
exchangeable), 7.33-7.47 (m, 10H, ArH); 4c :
'HNMR (OMSO-d6): 3.75 (t, 2H, -0-CH2CH2),
2.25 (t, 2H, -0-CH2CH2), 5.72 (s, 2H, NH2, 020-
exchangeable), 13.75 (s, IH, -NH-C=S, 020-
exchangeable), 7.20-7.80 (m, 10H, ArH), 4a : MS:
(mlz, ReI. Abund): 325 (M+, 10), 275 (25), 205
(100), 134 (50), 77 (90).
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